chr7-92447886-G-T
Variant summary
Our verdict is Likely benign. The variant received -1 ACMG points: 0P and 1B. BP4
The NM_021167.5(GATAD1):c.157G>T(p.Gly53Trp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000125 in 1,278,914 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G53R) has been classified as Uncertain significance.
Frequency
Consequence
NM_021167.5 missense
Scores
Clinical Significance
Conservation
Publications
- familial isolated dilated cardiomyopathyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- dilated cardiomyopathyInheritance: AR Classification: LIMITED Submitted by: ClinGen
- dilated cardiomyopathy 2BInheritance: AR Classification: LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -1 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_021167.5. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| GATAD1 | NM_021167.5 | MANE Select | c.157G>T | p.Gly53Trp | missense | Exon 1 of 5 | NP_066990.3 | ||
| GATAD1 | NR_052016.2 | n.405G>T | non_coding_transcript_exon | Exon 1 of 6 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| GATAD1 | ENST00000287957.5 | TSL:1 MANE Select | c.157G>T | p.Gly53Trp | missense | Exon 1 of 5 | ENSP00000287957.3 | ||
| GATAD1 | ENST00000644160.1 | n.13G>T | non_coding_transcript_exon | Exon 1 of 2 | |||||
| GATAD1 | ENST00000645746.1 | n.157G>T | non_coding_transcript_exon | Exon 1 of 6 | ENSP00000493785.1 |
Frequencies
GnomAD3 genomes AF: 0.0000790 AC: 12AN: 151936Hom.: 0 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.00 AC: 0AN: 7546 AF XY: 0.00
GnomAD4 exome AF: 0.00000355 AC: 4AN: 1126978Hom.: 0 Cov.: 30 AF XY: 0.00000185 AC XY: 1AN XY: 539858 show subpopulations
GnomAD4 genome AF: 0.0000790 AC: 12AN: 151936Hom.: 0 Cov.: 33 AF XY: 0.000162 AC XY: 12AN XY: 74234 show subpopulations
ClinVar
Submissions by phenotype
Dilated cardiomyopathy 2B Uncertain:1
This sequence change replaces glycine, which is neutral and non-polar, with tryptophan, which is neutral and slightly polar, at codon 53 of the GATAD1 protein (p.Gly53Trp). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with GATAD1-related conditions. ClinVar contains an entry for this variant (Variation ID: 574542). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.
Cardiovascular phenotype Uncertain:1
The p.G53W variant (also known as c.157G>T), located in coding exon 1 of the GATAD1 gene, results from a G to T substitution at nucleotide position 157. The glycine at codon 53 is replaced by tryptophan, an amino acid with highly dissimilar properties. This variant has been detected in an exertion-related sudden unexplained death cohort (Anderson JH et al. Circ Cardiovasc Genet, 2016 Jun;9:259-65). This amino acid position is well conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at